Market Closed -
Japan Exchange
02:00:00 2024-07-12 am EDT
|
5-day change
|
1st Jan Change
|
1,105
JPY
|
+1.84%
|
|
-2.21%
|
-22.07%
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
3,157
|
4,638
|
10,213
|
6,785
|
4,507
|
Enterprise Value (EV)
1 |
5,385
|
8,645
|
15,296
|
11,880
|
9,359
|
P/E ratio
|
27.3
x
|
82.8
x
|
25.2
x
|
75.7
x
|
23.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.41
x
|
0.51
x
|
0.88
x
|
0.5
x
|
0.27
x
|
EV / Revenue
|
0.7
x
|
0.95
x
|
1.32
x
|
0.87
x
|
0.56
x
|
EV / EBITDA
|
9,879,927
x
|
19,210,222
x
|
19,865,033
x
|
138,137,082
x
|
27,445,395
x
|
EV / FCF
|
-4,674,604
x
|
-5,583,014
x
|
-27,861,704
x
|
-10,282,193
x
|
21,956,316
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
2.95
x
|
4.11
x
|
7.52
x
|
4.61
x
|
2.71
x
|
Nbr of stocks (in thousands)
|
4,488
|
4,488
|
4,489
|
4,449
|
4,449
|
Reference price
2 |
703.3
|
1,033
|
2,275
|
1,525
|
1,013
|
Announcement Date
|
6/25/20
|
6/30/21
|
6/28/22
|
6/28/23
|
6/28/24
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
6,627
|
7,730
|
9,132
|
11,625
|
13,694
|
16,662
|
EBITDA
|
-
|
545
|
450
|
770
|
86
|
341
|
EBIT
1 |
329
|
329
|
220
|
469
|
-237
|
-82
|
Operating Margin
|
4.96%
|
4.26%
|
2.41%
|
4.03%
|
-1.73%
|
-0.49%
|
Earnings before Tax (EBT)
1 |
185
|
157
|
131
|
597
|
218
|
257
|
Net income
1 |
158
|
104
|
56
|
407
|
91
|
189
|
Net margin
|
2.38%
|
1.35%
|
0.61%
|
3.5%
|
0.66%
|
1.13%
|
EPS
2 |
39.35
|
25.73
|
12.48
|
90.13
|
20.15
|
42.39
|
Free Cash Flow
|
-
|
-1,152
|
-1,548
|
-549
|
-1,155
|
426.2
|
FCF margin
|
-
|
-14.9%
|
-16.96%
|
-4.72%
|
-8.44%
|
2.56%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
125%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
225.53%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/10/20
|
6/25/20
|
6/30/21
|
6/28/22
|
6/28/23
|
6/28/24
|
Fiscal Period: March |
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
2024 S2
|
---|
Net sales
1 |
4,277
|
5,321
|
3,110
|
3,338
|
6,715
|
3,482
|
3,959
|
8,111
|
4,182
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-12
|
246
|
163
|
116
|
179
|
-2
|
24
|
30
|
-96
|
-
|
Operating Margin
|
-0.28%
|
4.62%
|
5.24%
|
3.48%
|
2.67%
|
-0.06%
|
0.61%
|
0.37%
|
-2.3%
|
-
|
Earnings before Tax (EBT)
1 |
-104
|
471
|
98
|
118
|
125
|
-36
|
94
|
133
|
-10
|
-
|
Net income
1 |
-133
|
290
|
53
|
72
|
83
|
-40
|
51
|
79
|
5
|
-
|
Net margin
|
-3.11%
|
5.45%
|
1.7%
|
2.16%
|
1.24%
|
-1.15%
|
1.29%
|
0.97%
|
0.12%
|
-
|
EPS
2 |
-29.68
|
64.62
|
11.77
|
16.32
|
18.86
|
-9.050
|
11.67
|
17.81
|
1.220
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/13/20
|
11/12/21
|
2/14/22
|
8/12/22
|
11/14/22
|
2/14/23
|
8/14/23
|
11/14/23
|
2/14/24
|
5/15/24
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
2,476
|
2,228
|
4,007
|
5,083
|
5,095
|
4,852
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
4.088
x
|
8.904
x
|
6.601
x
|
59.24
x
|
14.23
x
|
Free Cash Flow
|
-
|
-1,152
|
-1,548
|
-549
|
-1,155
|
426
|
ROE (net income / shareholders' equity)
|
48.7%
|
14.1%
|
5.1%
|
32.9%
|
6.46%
|
12.1%
|
ROA (Net income/ Total Assets)
|
3.54%
|
3.24%
|
1.74%
|
2.96%
|
-1.33%
|
-0.45%
|
Assets
1 |
4,461
|
3,213
|
3,224
|
13,757
|
-6,841
|
-41,657
|
Book Value Per Share
2 |
101.0
|
238.0
|
251.0
|
303.0
|
331.0
|
373.0
|
Cash Flow per Share
2 |
277.0
|
363.0
|
354.0
|
394.0
|
423.0
|
254.0
|
Capex
|
-
|
1,338
|
1,570
|
1,081
|
824
|
629
|
Capex / Sales
|
-
|
17.31%
|
17.19%
|
9.3%
|
6.02%
|
3.78%
|
Announcement Date
|
2/10/20
|
6/25/20
|
6/30/21
|
6/28/22
|
6/28/23
|
6/28/24
|
|
1st Jan change
|
Capi.
|
---|
| -22.07% | 30.45M | | +19.70% | 83.16B | | -24.59% | 73.08B | | -1.34% | 26.15B | | +4.56% | 17.9B | | -8.57% | 17.39B | | +4.98% | 15.94B | | +77.38% | 13.61B | | +78.34% | 13.06B | | -26.14% | 12.76B |
Other Healthcare Facilities & Services
|